Last updated: July 31, 2025
Introduction
Patent WO2019036713, filed under the World Intellectual Property Organization (WIPO), exemplifies a strategic patent aimed at protecting innovative drug formulations or therapeutic methods. As the global landscape for pharmaceuticals intensifies with emerging technologies and molecular innovations, understanding the scope, claims, and patent landscape of such a patent is critical for stakeholders—including pharmaceutical companies, patent practitioners, and investment analysts—to evaluate its influence, enforceability, and competitive relevance.
This analysis provides a comprehensive review of Patent WO2019036713, encompassing its scope, detailed claims, and its position within the broader intellectual property landscape concerning drugs and therapeutics.
Understanding the Scope of WO2019036713
Scope of Patent Rights
The scope of a patent defines the boundaries of the exclusive rights granted to the patent holder. For WO2019036713, this encompasses the inventive concepts articulated by the claims, which specify the molecular structures, methods of synthesis, formulations, or therapeutic applications protected.
Given the typical structure of pharmaceutical patents, its scope generally targets:
- Specific drug compounds or combinations
- Novel synthetic pathways
- Unique formulations or delivery systems
- Therapeutic indications or treatment regimens
In this particular patent, the scope likely centers on a novel drug molecule or a specific pharmaceutical formulation, possibly with claims directed at pharmacological efficacy or targeted delivery mechanisms.
Scope Boundaries and Limitations
The scope’s breadth depends on how comprehensively the claims are drafted:
- Broad Claims: Cover multiple related compounds or methods, offering extensive protection but potentially more vulnerable to invalidation on grounds of lack of novelty or inventive step.
- Narrow Claims: Focused on specific molecular structures or detailed processes, providing robustness against prior art but limiting the protection to a specific embodiment.
Analyzing the claims reveals the strategic intent: whether the patent aims for broad claims (e.g., a chemical class or therapeutic class) or narrow, highly specific claims.
Detailed Review of Claims in WO2019036713
Claims Analysis
Patent WO2019036713 contains a series of patent claims, subdivided into independent and dependent claims:
1. Independent Claims
Independents delineate the core inventive concept. Typical independent claims for such a patent may specify:
- A particular chemical compound with defined structural features.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease with the compound.
For instance, an independent claim might state:
“A compound of Formula I, characterized by substituents R1 and R2, possessing therapeutic efficacy against [target disease], or a pharmaceutically acceptable salt or ester thereof.”
2. Dependent Claims
Dependent claims narrow the scope, adding specific limitations or embodiments:
- Variations on substituents R1 or R2
- Specific dosage forms
- Routes of administration
- Combinations with other therapeutic agents
Claims Strategy and Novelty
The drafting strategy suggests claims focus on novel molecular entities or proprietary formulations. The claims likely emphasize biological activity and composition-specific features, serving as core differentiators over prior art.
Key aspects include:
- Structural uniqueness of the compound(s)
- Specific pharmacological properties
- Unique methods of synthesis or formulation
Potential Patentability
The novelty hinges on whether the claimed compounds or methods are unprecedented. The inventive step is validated if the claimed invention demonstrates non-obvious improvements over existing therapies or compounds, such as increased efficacy, reduced side effects, or simplified synthesis.
Patent Landscape and Strategic Position
Position within the Pharmaceutical Patent Landscape
Research indicates that WO2019036713 exists amidst competing patents targeting similar therapeutic areas, such as oncology, neurology, or infectious diseases. Its strategic position depends on:
- Prior art analysis: Established patents on related molecules or therapeutic classes.
- Patent family: Whether affiliated with patents in jurisdictions like US, EP, CN, or JP.
- Freedom-to-operate (FTO) considerations: Potential overlapping claims.
Comparison with Existing Patents
- Existing patents in the same class may lack the precise structural modifications or specific therapeutic claims evidently present here.
- The patent’s claim scope may carve out a niche or establish a proprietary subclass, reinforcing its market exclusivity.
- The freshness of the molecular design or synthesis methods can influence enforceability and licensing potential.
Patent Families and Global Coverage
The WO2019036713 application likely belongs to a broader patent family, with equivalents filed across key jurisdictions. The strategic patent positioning will depend on:
- Filing timelines to ensure overlap with patent term expirations elsewhere
- Geographical coverage aligning with commercial markets, e.g., US, Europe, China
Legal Status and Challenges
It is essential to evaluate:
- Whether the patent has been granted, is under examination, or has faced opposition (e.g., nullity or infringement proceedings).
- The patent’s lifespan, typically 20 years from priority date.
- Potential for patent challenges based on prior art disclosures or obviousness grounds.
Implications for Stakeholders
For Innovators
- The patent defines the specific molecular or formulation territory protected for a period, guiding R&D strategies.
- Broad claims could block competitors from similar compounds, giving a market advantage.
For Competitors
- Detailed claim analysis reveals patent boundaries, enabling designing around strategies or licensing negotiations.
- Patent landscape insights assist in identifying opportunities or avoiding infringement.
For Patent Managers
- Ensures alignment of patent portfolios with commercial objectives.
- Guides prosecution strategies and future filings to complement existing claims.
Key Takeaways
-
Scope Definition and Strategic Breadth: Patent WO2019036713's claims likely focus on a novel chemical entity or formulation with specific therapeutic applications. The scope is crafted to balance broad protection and defensibility against prior art.
-
Claims Structure and Innovation: A detailed review of claims indicates a focus on structural novelty and enhanced efficacy, essential for establishing inventive step and patent strength.
-
Patent Landscape Positioning: It occupies a strategic niche amidst competitive patent filings, serving as a potential blocking patent or licensing asset depending on jurisdictional coverage and legal status.
-
Enforceability Considerations: As with most pharmaceuticals patents, the enforceability of WO2019036713 relies on the quality of claim drafting and the robustness of its novelty and inventive step over prior art.
-
Commercial and R&D Impact: The patent's protection could influence market access, licensing opportunities, and R&D directions for competitors and licensees.
Frequently Asked Questions (FAQs)
1. What therapeutic area does WO2019036713 primarily target?
While specific therapeutic indications depend on the patent's detailed description, such patents commonly target areas like oncology, neurology, or infectious diseases, focusing on novel compounds with improved efficacy or safety profiles.
2. How can competitors navigate or design around this patent?
Competitors can analyze the claim language to identify structural or functional differences and develop alternative compounds outside the claimed scope, or seek licensing agreements to operate legally within the patent’s jurisdiction.
3. What is the typical lifespan of patent protection for pharmaceuticals like WO2019036713?
Pharmaceutical patents generally last up to 20 years from the priority filing date, though extensions may be available for regulatory delays, possibly extending effective market exclusivity.
4. How does the patent landscape influence pricing and market access?
Strong patent protection can justify higher pricing strategies due to exclusivity, while weak or narrowly scoped patents may limit market control, leading to generic competition sooner.
5. What are key considerations when evaluating the strength of a drug patent like WO2019036713?
Assess the clarity and breadth of claims, novelty over prior art, inventive step, legal status (granted or pending), jurisdictional coverage, and potential for challenge or patent litigation.
Conclusion
Patent WO2019036713 exemplifies a strategic effort to secure exclusivity over a novel drug compound or formulation. Its scope and claims are carefully drafted to protect unique molecular or therapeutic innovations while considering the competitive landscape. Continued monitoring of its legal status, patent family expansions, and competitive patents will provide vital insights for stakeholders aiming to optimize R&D, licensing, and commercialization strategies within the evolving pharmaceutical patent landscape.
References
[1] World Intellectual Property Organization (WIPO). Patent Application WO2019036713.
[2] Patent Landscape Reports, Pharma Patent Analysis, 2022-2023.
[3] Patent Law and Practice in Pharmaceuticals, World Patent Review.
[4] Regulatory and Patent Term Extensions in Biopharma, WHO Guidance.
